Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

Causes of diabetes decline or disappear when ‘zombie cells’ are removed, shows study

Mayo Clinic researchers and their collaborators have shown that when senescent cells -- also known as "zombie cells" -- are removed from fat tissue in obese mice, severity of diabetes and a range of its causes or consequences decline or disappear. The findings appear in Aging Cell.

26 Mar 2019

Luxia Scientific partners with Life Genomics to commercialize microbiome-based tests in the Nordic countries

Luxia Scientific, a French biotech dedicated to improving wellbeing and health for all through the analysis and understanding of the microbiome, announced today that it has signed an exclusive distribution agreement with Life Genomics to commercialize « 1test1TM » in Nordic countries.

From Luxia Scientific 25 Mar 2019

Antidepressant drugs may not work when neurons are out of shape

elective serotonin reuptake inhibitors are the most commonly prescribed medication for major depressive disorder, yet scientists still do not understand why the treatment does not work in nearly thirty percent of patients with MDD.

22 Mar 2019

Bacteria and innate immune factors in birth canal, cervix may be key to predicting preterm births

Spontaneous preterm birth, defined as birth before 37 weeks of gestation, and the related complications, are the largest contributors to infant death in the United States and worldwide, according to the World Health Organization.

22 Mar 2019

City of Hope exhibits current studies and data on cancer therapies at AACR

City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, will showcase ongoing studies and data on chimeric antigen receptor T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

22 Mar 2019

Knowing causative genes of osteoporosis may open door to more effective treatments

Scientists have harnessed powerful data analysis tools and three-dimensional studies of genomic geography to implicate new risk genes for osteoporosis, the chronic bone-weakening condition that affects millions of people.

22 Mar 2019

New computer program developed by TGen lights up cancer-causing genetic mutations

By conjuring the spell "Lumos!" wizards in the mythical world of Harry Potter could light up the tip of their magic wands and illuminate their surroundings. So, too, does LumosVar, a computer program developed by the Translational Genomics Research Institute, "light up" cancer-causing genetic Var-ients, or mutations, illuminating how physicians might best treat their patients.

21 Mar 2019

TGen and ABL sign agreement to distribute new TB test technology

n an important step toward eradicating tuberculosis, the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced Biological Laboratories, to market and distribute TGen's patented Next Generation Sequencing-based TB test technology.

19 Mar 2019

First African-American Neuroscience Research Initiative launched to close the gap in health disparities

The nation's first African-American Neuroscience Research Initiative, aimed at ensuring that genomic research and neuroscience studies are representative of individuals across all populations including African ancestry, launched today.

19 Mar 2019

Natural speed limit on DNA replication sets pace for life's first steps

Fruit flies make for stingy mothers, imparting only a portion of the genetic building blocks their offspring need to survive. The rest must be produced by the fertilized egg in its first few steps of growth.

15 Mar 2019

An Insider’s Guide to the chemagic™ Prime™ Junior Instrument

Masoud Toloue from PerkinElmer provides an overview of the chemagic Prime Junior Instrument and gives his inside tips for scientists working with nucleic acids.

From Revvity 14 Mar 2019

Columbia researchers explore molecular mechanisms of treatment-resistant depression

Major depressive disorder is a debilitating illness that affects more than 350 million people around the world.

14 Mar 2019

New method for on-the-spot genome analysis

The ability to read the genome - all the DNA of an organism - has vast potential to understand human health and disease.

14 Mar 2019

PNAS publishes results of pilot study for early detection of liver cancer

Today, Proceedings of the National Academy of Sciences published the results of a pilot study for early detection of liver cancer in a cohort of HBV carriers, who are at risk for developing this disease.

13 Mar 2019

Precision cancer drugs spark powerful immune response and boost effects of immunotherapy

Precision cancer drugs called PARP inhibitors have a previously unknown ability to boost the immune system, and could help many more patients benefit from immunotherapy, a new study reveals.

11 Mar 2019

Quanterix corporation releases operating results for fourth quarter and full year 2018

Quanterix announced financial results for the three months and twelve months ended Dec. 31, 2018.

From Quanterix 7 Mar 2019

New mathematical method to map cell regulatory networks

Faster results. Lower costs. Fewer cells. A new mathematical method developed by researchers at Cincinnati Children's and New York University may soon make it much easier to conduct more of the complex data analysis needed to drive advances in the exploding field of personalized medicine.

6 Mar 2019

Genomics could guide treatment for pancreatic cancer patients

Pancreatic cancer is a grim diagnosis, with a five-year survival rate of less than 9 percent. To improve those odds, researchers at UPMC and the University of Pittsburgh School of Medicine sought genetic signatures in the largest study of its kind that could be used to better match drugs to patients and for early detection.

5 Mar 2019

New combinational drug therapy may effectively combat pancreatic cancer

Even among cancers, pancreatic cancer is an especially sinister form of disease. The one-year survival rate is extremely low, and treatment progress has lagged behind that of many other malignancies.

5 Mar 2019

Causes of disease including infant cancer can be revealed with new tool from Princeton University research team

Machine learning is being used to gain insight into the causes of hundreds of diseases, with Princeton University researchers discovering four specific genes that contribute to infant cancer.

4 Mar 2019

Genomics News and Research

Further Reading

Causes of diabetes decline or disappear when ‘zombie cells’ are removed, shows study

Luxia Scientific partners with Life Genomics to commercialize microbiome-based tests in the Nordic countries

Antidepressant drugs may not work when neurons are out of shape

Bacteria and innate immune factors in birth canal, cervix may be key to predicting preterm births

City of Hope exhibits current studies and data on cancer therapies at AACR

Knowing causative genes of osteoporosis may open door to more effective treatments

New computer program developed by TGen lights up cancer-causing genetic mutations

TGen and ABL sign agreement to distribute new TB test technology

First African-American Neuroscience Research Initiative launched to close the gap in health disparities

Natural speed limit on DNA replication sets pace for life's first steps

An Insider’s Guide to the chemagic™ Prime™ Junior Instrument

Columbia researchers explore molecular mechanisms of treatment-resistant depression

New method for on-the-spot genome analysis

PNAS publishes results of pilot study for early detection of liver cancer

Precision cancer drugs spark powerful immune response and boost effects of immunotherapy

Quanterix corporation releases operating results for fourth quarter and full year 2018

New mathematical method to map cell regulatory networks

Genomics could guide treatment for pancreatic cancer patients

New combinational drug therapy may effectively combat pancreatic cancer

Causes of disease including infant cancer can be revealed with new tool from Princeton University research team

Sequencing & Genomics: Elevating Science and Healthcare eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo